|
Volumn 21, Issue 5, 2000, Pages 371-381
|
Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUIT
a,g a a b c b d e f e b a |
Author keywords
Acute coronary syndromes; Geographic variation; Myocardial infarction; Platelet glycoprotein IIb IIIa receptor inhibition; Unstable angina
|
Indexed keywords
CREATINE KINASE;
EPTIFIBATIDE;
FIBRINOGEN RECEPTOR;
GLYCOPROTEIN;
PLACEBO;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CREATINE KINASE BLOOD LEVEL;
DEATH;
DISEASE CLASSIFICATION;
DOUBLE BLIND PROCEDURE;
EASTERN EUROPE;
FEMALE;
GEOGRAPHIC DISTRIBUTION;
HEART INFARCTION;
HUMAN;
ISCHEMIC HEART DISEASE;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
MULTIVARIATE ANALYSIS;
NORTH AMERICA;
PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REVASCULARIZATION;
RISK;
SOUTH AND CENTRAL AMERICA;
TREATMENT OUTCOME;
WESTERN EUROPE;
AGED;
CORONARY DISEASE;
DOUBLE-BLIND METHOD;
EUROPE;
FEMALE;
HUMANS;
LATIN AMERICA;
MALE;
MIDDLE AGED;
MULTIVARIATE ANALYSIS;
MYOCARDIAL INFARCTION;
NORTH AMERICA;
ODDS RATIO;
PEPTIDES;
PLATELET AGGREGATION INHIBITORS;
PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 0033981265
PISSN: 0195668X
EISSN: None
Source Type: Journal
DOI: 10.1053/euhj.1999.1743 Document Type: Article |
Times cited : (68)
|
References (31)
|